ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,527Medicare Part D Prescriptions Filled, Including Refills

Rank: 34 out of 434

$491K Total Retail Price of All Prescriptions

Rank: 42 out of 434

516 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 516 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

16% of this provider’s 516 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 8,597 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
WARFARIN SODIUM 554 513 1 18
LEVOTHYROXINE SODIUM 447 355 2 3
LISINOPRIL 393 319 3 1
FUROSEMIDE 360 295 4 9
SIMVASTATIN 348 260 5 2
HYDROCODONE-ACETAMINOPHEN 312 211 S3 6 4
METFORMIN HCL 275 188 7 7
OMEPRAZOLE 252 205 8 5
LOSARTAN POTASSIUM 243 228 9 13
POTASSIUM CHLORIDE 241 216 10 20
AMLODIPINE BESYLATE 237 197 11 6
CARVEDILOL 220 151 12 24
LOVASTATIN 218 144 13 10
GABAPENTIN 201 132 14 14
METOPROLOL TARTRATE 174 152 15 12
ZOLPIDEM TARTRATE 150 85 16 11
FLUTICASONE PROPIONATE 146 113 17 26
CITALOPRAM HBR 129 95 18 23
LANTUS SOLOSTAR 126 62 19 71
OXYCODONE HCL 122 78 S2 20 34
OXYCODONE-ACETAMINOPHEN 106 65 S2 21 74
MORPHINE SULFATE ER 100 0 S2 22 50
ATORVASTATIN CALCIUM 95 77 23 19
HYDROCHLOROTHIAZIDE 91 90 24 8
TAMSULOSIN HCL 86 72 25 29
BROVANA 84 73 10 26 236
SPIRIVA 82 73 27 36
BACLOFEN 79 31 28 77
AMIODARONE HCL 77 57 29 153
ATENOLOL 77 54 29 16
ALLOPURINOL 77 76 29 25
TRAMADOL HCL 75 67 32 28
ENALAPRIL MALEATE 71 62 33 59
BENAZEPRIL HCL 71 44 33 49
ALENDRONATE SODIUM 70 67 35 15
ENOXAPARIN SODIUM 70 37 35 197
OXYBUTYNIN CHLORIDE 69 51 37 82
LANSOPRAZOLE 66 55 38 194
SERTRALINE HCL 66 53 38 27
PANTOPRAZOLE SODIUM 63 60 40 66
RISPERIDONE 63 48 40 87
TRIAMCINOLONE ACETONIDE 62 53 42 94
CLONIDINE HCL 60 30 43 63
GLIPIZIDE 59 46 44 37
TRAZODONE HCL 59 33 44 33
ONDANSETRON HCL 57 45 46 272
DOXAZOSIN MESYLATE 56 38 47 111
PROAIR HFA 56 36 47 60
PREDNISONE 55 40 49 42
AZITHROMYCIN 54 40 50 38
CYMBALTA 53 24 51 109
NOVOLIN R 53 26 51 281
CLOPIDOGREL 52 37 53 41
IPRATROPIUM-ALBUTEROL 51 39 54 213
FLUOXETINE HCL 51 44 54 32
ZETIA 51 50 54 127
PLAVIX 50 33 57 64
LIDOCAINE HCL 50 34 57 290
SPIRONOLACTONE 50 37 57 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 27, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.